Patents

US 11918603 B2: Ocular lubricant formulations

Granted
2024-03-05
Filed
2019-08-27 application 17268256
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are formulations and compositions for ocular diseases or disorders such as dry eye disease. Further provided herein are methods for manufacturing ocular formulations and compositions.

Source: PVGPATDIS, file of 2026-04-10 (ipg240305.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
HARROW IP, LLC 15 patentsUS company or organizationNashville, TNPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
William StringerPortland, OR4PVGPATDIS, file of 2026-04-10
Michael HanrahanPortland, OR2PVGPATDIS, file of 2026-04-10
Patrick H. WithamPortland, OR12PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/79PVGPATDIS, file of 2026-04-10
A61FFilters implantable into blood vessels; prostheses; devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents; orthopaedic, nursing or contraceptive devices; fomentation; treatment or protection of eyes or ears; bandages, dressings or absorbent pads; first-aid kitsA61F9/0008PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P27/04PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-09-26Security interest Security interest
Security interest
HARROW, INC. signed 2025-09-26
HARROW IP, LLC signed 2025-09-26
FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT ROSEMONT, IL72384/781PASDL, file of 2026-10-15
2025-09-17Release of security interest
Release of security interest
OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT signed 2025-09-12HARROW IP, LLC NASHVILLE, TN72280/573ECORSEXC, file of 2026-09-25
2023-08-18Correction
Supplemental patent security agreement (first supplemental filing)
HARROW IP, LLC signed 2023-08-17OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT LOS ANGELES, CA64640/535ECORSEXC, file of 2026-09-25
2023-08-02Assignment
Assignment of assignor's interest
EYEVANCE PHARMACEUTICALS LLC signed 2023-08-01HARROW IP, LLC NASHVILLE, TN64468/450ECORSEXC, file of 2026-09-25
2022-01-13Assignment
Assignment of assignor's interest
WITHAM, PATRICK H. signed 2021-07-07
HANRAHAN, MICHAEL signed 2021-12-29
STRINGER, WILLIAM signed 2022-01-04
EYEVANCE PHARMACEUTICALS LLC FORT WORTH, TX58646/859ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.